Amgen Inc. (AMGN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
157.97-0.79 (-0.50%)
As of 3:38 PM EDT. Market open.
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close158.76
Bid157.86 x 200
Ask157.87 x 100
Day's Range157.80 - 159.27
52wk Range139.02 - 176.85
1y Target EstN/A
Market Cap118.22B
P/E Ratio (ttm)16.17
Avg Vol (3m)2,805,238
Dividend & Yield4.00 (2.52%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • PR Newswire10 hours ago

    Amgen To Invest In Israel-Based eHealth Ventures

    ZUG, Switzerland, Oct. 25, 2016 /PRNewswire/ -- Amgen (Europe) GmbH, an affiliate of Amgen Inc. (AMGN) (collectively, "Amgen") today announced an investment in eHealth Ventures, an Israel-based digital health incubator. The investment reflects Amgen's commitment to serving patients by driving innovation and sustainable healthcare through technology discovery, and recognizes the importance of Israel as a source of innovation in eHealth and digital technologies. Additional investors include Israeli HMO Maccabi Healthcare Services and Amgen's Israeli distributor Medison Pharma Ltd. Amgen will be the lead biopharmaceutical investor.

  • MarketWatchyesterday

    Index funds can be inferior to active funds in two crucial ways

    The careful selection of dividend stocks can pave the way to a growing income stream, says Phil van Doorn.

  • PR Newswireyesterday

    Amgen Announces Webcast Of 2016 Third Quarter Financial Results

    THOUSAND OAKS, Calif., Oct. 24, 2016 /PRNewswire/ -- Amgen (AMGN) today announced that it will report its third quarter financial results on Thursday, Oct. 27, 2016, after the close of the U.S. financial markets. Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team. The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website,, under Investors.